trial

Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics

NCTId NCT00224276
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 100
Sponsored by Yale University
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
100
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
—
Primary completion
—
Eligibility
ALL · 0 Years

Interventions & indications

Drugs
—

Sponsors

Yale UniversityLead Sponsor
Janssen, L.P. - Investigator Initiated Studies ProgramCollaborator

Investigators

1
Scott W. Woods, MDPrincipal Investigator

Sites

0 total

Facts & assertions

3 sourced
Enrollment
100
Phase
NA
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
Yale University
company
collaborator
Janssen, L.P. - Investigator Initiated Studies Program
company
indication
Bipolar Disorder
indication
Diabetes Mellitus
indication
Diabetes Mellitus
indication
investigator
Scott W. Woods, MD
person